and beta-amyloid 42/40 ratio tests, as well as the ATN Profile, which combines three blood indicators. Beyond diagnostics, Labcorp plays a larger role in the healthcare sector as a drug research ...

according to Labcorp in the 20 March press release. The test is not US Food and Drug Administration (FDA) approved. A recent change to FDA rules now means that laboratory-developed tests (LDT ...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But ...

Labcorp will acquire BioReference Health's oncology diagnostics operations as the lab company works to expand in high-growth ...

The antiviral drug remdesivir received emergency use ... were developed and implemented by Monogram Biosciences, a Labcorp specialty testing laboratory to study HIV-neutralizing antibodies nearly ...

Learn more about us at www.labcorp.com. i This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.

This acquisition further solidifies Labcorp's position as an industry leader in oncology, expanding its extensive portfolio of diagnostic tests in cancer care. "By integrating BioReference Health ...

Labcorp Holdings Inc. LH, or Labcorp, is prioritizing key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, aiming to tap into strong growth opportunities.

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today ...